Structure

Physi-Chem Properties

Molecular Weight:  546.15
Volume:  544.202
LogP:  4.357
LogD:  2.637
LogS:  -3.299
# Rotatable Bonds:  7
TPSA:  181.8
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.173
Synthetic Accessibility Score:  3.404
Fsp3:  0.133
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.658
MDCK Permeability:  1.2235095709911548e-05
Pgp-inhibitor:  0.026
Pgp-substrate:  0.958
Human Intestinal Absorption (HIA):  0.089
20% Bioavailability (F20%):  0.32
30% Bioavailability (F30%):  0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.002
Plasma Protein Binding (PPB):  100.00607299804688%
Volume Distribution (VD):  0.155
Pgp-substrate:  0.9310187101364136%

ADMET: Metabolism

CYP1A2-inhibitor:  0.266
CYP1A2-substrate:  0.877
CYP2C19-inhibitor:  0.175
CYP2C19-substrate:  0.046
CYP2C9-inhibitor:  0.757
CYP2C9-substrate:  0.911
CYP2D6-inhibitor:  0.045
CYP2D6-substrate:  0.872
CYP3A4-inhibitor:  0.114
CYP3A4-substrate:  0.168

ADMET: Excretion

Clearance (CL):  5.989
Half-life (T1/2):  0.745

ADMET: Toxicity

hERG Blockers:  0.143
Human Hepatotoxicity (H-HT):  0.738
Drug-inuced Liver Injury (DILI):  0.98
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.164
Maximum Recommended Daily Dose:  0.904
Skin Sensitization:  0.969
Carcinogencity:  0.131
Eye Corrosion:  0.003
Eye Irritation:  0.659
Respiratory Toxicity:  0.036

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC20853

Natural Product ID:  NPC20853
Common Name*:   Rubiyunnanol A
IUPAC Name:   (1R,3S,3aS,5aR,7aR,9S,11aS,13aR,13bS)-3a,5a,8,8,11a,13a-hexamethyl-3-propan-2-yl-1,2,3,4,5,7,7a,9,10,11,13,13b-dodecahydrocyclopenta[a]chrysene-1,9-diol
Synonyms:   rubiyunnanol A
Standard InCHIKey:  VGCPCEYHYXKGCA-ZMTMDZEFSA-N
Standard InCHI:  InChI=1S/C30H48O2/c1-18(2)21-17-22(31)25-28(21,6)15-16-29(7)20-9-10-23-26(3,4)24(32)12-13-27(23,5)19(20)11-14-30(25,29)8/h9,11,18,21-25,31-32H,10,12-17H2,1-8H3/t21-,22+,23-,24-,25-,27+,28-,29-,30+/m0/s1
SMILES:  CC(C)[C@@H]1C[C@H]([C@H]2[C@@]1(C)CC[C@@]1(C)C3=CC[C@H]4C(C)(C)[C@H](CC[C@]4(C)C3=CC[C@]21C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1835872
PubChem CID:   56599863
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[12350148]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[12762798]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[21044847]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota roots n.a. n.a. PMID[21973054]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. root n.a. PMID[21973054]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 = 9800.0 nM PMID[518073]
NPT165 Cell Line HeLa Homo sapiens IC50 > 10000.0 nM PMID[518073]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC20853 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9487 High Similarity NPC201852
0.9351 High Similarity NPC1319
0.9268 High Similarity NPC470542
0.9221 High Similarity NPC205455
0.9221 High Similarity NPC186191
0.9114 High Similarity NPC6707
0.9091 High Similarity NPC214570
0.9012 High Similarity NPC209802
0.9 High Similarity NPC202389
0.8974 High Similarity NPC72507
0.8974 High Similarity NPC318136
0.8974 High Similarity NPC477522
0.8974 High Similarity NPC275910
0.8961 High Similarity NPC202642
0.8961 High Similarity NPC46160
0.8961 High Similarity NPC189883
0.8961 High Similarity NPC73875
0.8916 High Similarity NPC271967
0.8831 High Similarity NPC141071
0.8831 High Similarity NPC322353
0.8831 High Similarity NPC471723
0.8831 High Similarity NPC118508
0.8831 High Similarity NPC121744
0.8831 High Similarity NPC257347
0.8816 High Similarity NPC201373
0.881 High Similarity NPC2158
0.8795 High Similarity NPC24277
0.878 High Similarity NPC231310
0.878 High Similarity NPC124172
0.875 High Similarity NPC26117
0.875 High Similarity NPC236112
0.8734 High Similarity NPC307965
0.8734 High Similarity NPC477514
0.8734 High Similarity NPC167037
0.8734 High Similarity NPC285761
0.8734 High Similarity NPC18603
0.8734 High Similarity NPC76931
0.8734 High Similarity NPC244385
0.8734 High Similarity NPC6978
0.8734 High Similarity NPC138621
0.8718 High Similarity NPC300324
0.8718 High Similarity NPC96319
0.8718 High Similarity NPC106432
0.8718 High Similarity NPC321016
0.8718 High Similarity NPC321381
0.8718 High Similarity NPC240604
0.8718 High Similarity NPC237460
0.8718 High Similarity NPC134330
0.8718 High Similarity NPC107059
0.8718 High Similarity NPC129165
0.8718 High Similarity NPC470362
0.8675 High Similarity NPC318390
0.8659 High Similarity NPC477818
0.8659 High Similarity NPC110778
0.8642 High Similarity NPC474531
0.8625 High Similarity NPC30986
0.8625 High Similarity NPC80530
0.8625 High Similarity NPC209430
0.8625 High Similarity NPC273410
0.8608 High Similarity NPC155986
0.8608 High Similarity NPC198968
0.8608 High Similarity NPC318495
0.8605 High Similarity NPC107189
0.859 High Similarity NPC285893
0.859 High Similarity NPC304309
0.859 High Similarity NPC230301
0.859 High Similarity NPC162742
0.859 High Similarity NPC134847
0.859 High Similarity NPC288035
0.859 High Similarity NPC22105
0.859 High Similarity NPC28657
0.859 High Similarity NPC136188
0.8554 High Similarity NPC238485
0.8537 High Similarity NPC1272
0.8537 High Similarity NPC30166
0.8537 High Similarity NPC248886
0.8537 High Similarity NPC87489
0.8537 High Similarity NPC470049
0.8537 High Similarity NPC470614
0.8519 High Similarity NPC102253
0.8519 High Similarity NPC236237
0.8519 High Similarity NPC322313
0.8519 High Similarity NPC13554
0.85 High Similarity NPC474216
0.85 High Similarity NPC42853
0.85 High Similarity NPC87604
0.85 High Similarity NPC302041
0.85 High Similarity NPC473943
0.85 High Similarity NPC85346
0.85 High Similarity NPC65897
0.8488 Intermediate Similarity NPC105495
0.8481 Intermediate Similarity NPC113733
0.8471 Intermediate Similarity NPC475772
0.8462 Intermediate Similarity NPC100334
0.8442 Intermediate Similarity NPC110799
0.8434 Intermediate Similarity NPC237795
0.8434 Intermediate Similarity NPC82538
0.8434 Intermediate Similarity NPC470384
0.8434 Intermediate Similarity NPC193870
0.8434 Intermediate Similarity NPC141941
0.8415 Intermediate Similarity NPC470383
0.8395 Intermediate Similarity NPC84694
0.8395 Intermediate Similarity NPC49599
0.8395 Intermediate Similarity NPC49627
0.8395 Intermediate Similarity NPC143182
0.8395 Intermediate Similarity NPC328714
0.8395 Intermediate Similarity NPC109546
0.8395 Intermediate Similarity NPC28862
0.8395 Intermediate Similarity NPC47982
0.8395 Intermediate Similarity NPC81306
0.8375 Intermediate Similarity NPC40394
0.8375 Intermediate Similarity NPC157996
0.8375 Intermediate Similarity NPC34019
0.8375 Intermediate Similarity NPC101475
0.8375 Intermediate Similarity NPC34177
0.8375 Intermediate Similarity NPC472805
0.8375 Intermediate Similarity NPC90979
0.8372 Intermediate Similarity NPC280556
0.8354 Intermediate Similarity NPC231256
0.8354 Intermediate Similarity NPC138374
0.8354 Intermediate Similarity NPC34700
0.8354 Intermediate Similarity NPC104387
0.8354 Intermediate Similarity NPC240235
0.8354 Intermediate Similarity NPC471468
0.8354 Intermediate Similarity NPC178383
0.8354 Intermediate Similarity NPC212879
0.8353 Intermediate Similarity NPC201273
0.8333 Intermediate Similarity NPC474140
0.8333 Intermediate Similarity NPC478102
0.8333 Intermediate Similarity NPC470077
0.8333 Intermediate Similarity NPC474493
0.8333 Intermediate Similarity NPC475798
0.8333 Intermediate Similarity NPC127606
0.8333 Intermediate Similarity NPC182717
0.8313 Intermediate Similarity NPC49964
0.8313 Intermediate Similarity NPC218616
0.8313 Intermediate Similarity NPC101462
0.8313 Intermediate Similarity NPC296701
0.8313 Intermediate Similarity NPC5985
0.8293 Intermediate Similarity NPC22403
0.8293 Intermediate Similarity NPC241290
0.8293 Intermediate Similarity NPC234193
0.8293 Intermediate Similarity NPC164840
0.8293 Intermediate Similarity NPC209944
0.8276 Intermediate Similarity NPC84271
0.8276 Intermediate Similarity NPC102414
0.8276 Intermediate Similarity NPC77168
0.8272 Intermediate Similarity NPC253807
0.8272 Intermediate Similarity NPC230295
0.8272 Intermediate Similarity NPC22955
0.8272 Intermediate Similarity NPC477819
0.8272 Intermediate Similarity NPC196753
0.8272 Intermediate Similarity NPC474989
0.8272 Intermediate Similarity NPC477817
0.8272 Intermediate Similarity NPC312328
0.8272 Intermediate Similarity NPC158662
0.8272 Intermediate Similarity NPC300499
0.8272 Intermediate Similarity NPC98386
0.8272 Intermediate Similarity NPC470396
0.8272 Intermediate Similarity NPC99168
0.825 Intermediate Similarity NPC14112
0.825 Intermediate Similarity NPC290598
0.825 Intermediate Similarity NPC30590
0.825 Intermediate Similarity NPC93662
0.825 Intermediate Similarity NPC122418
0.825 Intermediate Similarity NPC120098
0.825 Intermediate Similarity NPC265328
0.825 Intermediate Similarity NPC244488
0.825 Intermediate Similarity NPC278091
0.825 Intermediate Similarity NPC86305
0.825 Intermediate Similarity NPC78067
0.825 Intermediate Similarity NPC247325
0.825 Intermediate Similarity NPC27765
0.8235 Intermediate Similarity NPC474349
0.8235 Intermediate Similarity NPC474189
0.8228 Intermediate Similarity NPC62657
0.8228 Intermediate Similarity NPC192638
0.8228 Intermediate Similarity NPC477138
0.8228 Intermediate Similarity NPC469593
0.8228 Intermediate Similarity NPC243342
0.8228 Intermediate Similarity NPC25511
0.8228 Intermediate Similarity NPC469534
0.8228 Intermediate Similarity NPC329090
0.8228 Intermediate Similarity NPC469533
0.8228 Intermediate Similarity NPC27395
0.8228 Intermediate Similarity NPC91858
0.8222 Intermediate Similarity NPC162001
0.8222 Intermediate Similarity NPC222845
0.8222 Intermediate Similarity NPC45324
0.8214 Intermediate Similarity NPC113978
0.8214 Intermediate Similarity NPC207013
0.8214 Intermediate Similarity NPC317458
0.8205 Intermediate Similarity NPC167706
0.8205 Intermediate Similarity NPC111234
0.8193 Intermediate Similarity NPC474759
0.8193 Intermediate Similarity NPC47761
0.8193 Intermediate Similarity NPC82986
0.8193 Intermediate Similarity NPC7505
0.8193 Intermediate Similarity NPC264245
0.8193 Intermediate Similarity NPC474752

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC20853 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8718 High Similarity NPD3701 Clinical (unspecified phase)
0.859 High Similarity NPD6942 Approved
0.859 High Similarity NPD7339 Approved
0.8519 High Similarity NPD7525 Registered
0.8293 Intermediate Similarity NPD4748 Discontinued
0.8228 Intermediate Similarity NPD6926 Approved
0.8228 Intermediate Similarity NPD6924 Approved
0.8205 Intermediate Similarity NPD4243 Approved
0.8171 Intermediate Similarity NPD7645 Phase 2
0.8025 Intermediate Similarity NPD6933 Approved
0.8 Intermediate Similarity NPD4785 Approved
0.8 Intermediate Similarity NPD4784 Approved
0.7975 Intermediate Similarity NPD7150 Approved
0.7975 Intermediate Similarity NPD7152 Approved
0.7975 Intermediate Similarity NPD7151 Approved
0.7949 Intermediate Similarity NPD6923 Approved
0.7949 Intermediate Similarity NPD6922 Approved
0.7907 Intermediate Similarity NPD4786 Approved
0.7865 Intermediate Similarity NPD5328 Approved
0.7848 Intermediate Similarity NPD7143 Approved
0.7848 Intermediate Similarity NPD7144 Approved
0.7841 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7802 Intermediate Similarity NPD4202 Approved
0.7738 Intermediate Similarity NPD6929 Approved
0.7727 Intermediate Similarity NPD3618 Phase 1
0.7701 Intermediate Similarity NPD3665 Phase 1
0.7701 Intermediate Similarity NPD3133 Approved
0.7701 Intermediate Similarity NPD3666 Approved
0.7692 Intermediate Similarity NPD6079 Approved
0.7683 Intermediate Similarity NPD4190 Phase 3
0.7683 Intermediate Similarity NPD5275 Approved
0.7674 Intermediate Similarity NPD3667 Approved
0.7647 Intermediate Similarity NPD6930 Phase 2
0.7647 Intermediate Similarity NPD7509 Discontinued
0.7647 Intermediate Similarity NPD6931 Approved
0.7529 Intermediate Similarity NPD4195 Approved
0.7528 Intermediate Similarity NPD5279 Phase 3
0.75 Intermediate Similarity NPD6925 Approved
0.75 Intermediate Similarity NPD6932 Approved
0.75 Intermediate Similarity NPD5776 Phase 2
0.7474 Intermediate Similarity NPD4755 Approved
0.747 Intermediate Similarity NPD8264 Approved
0.7416 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD7145 Approved
0.7386 Intermediate Similarity NPD6695 Phase 3
0.7333 Intermediate Similarity NPD4694 Approved
0.7333 Intermediate Similarity NPD5280 Approved
0.7326 Intermediate Similarity NPD6683 Phase 2
0.732 Intermediate Similarity NPD4700 Approved
0.732 Intermediate Similarity NPD5285 Approved
0.732 Intermediate Similarity NPD5286 Approved
0.732 Intermediate Similarity NPD4696 Approved
0.7303 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD4753 Phase 2
0.7273 Intermediate Similarity NPD4221 Approved
0.7273 Intermediate Similarity NPD4223 Phase 3
0.7245 Intermediate Similarity NPD5223 Approved
0.7241 Intermediate Similarity NPD7514 Phase 3
0.7222 Intermediate Similarity NPD5329 Approved
0.7222 Intermediate Similarity NPD6893 Approved
0.7209 Intermediate Similarity NPD7322 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD4787 Phase 1
0.7188 Intermediate Similarity NPD4697 Phase 3
0.7188 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD5221 Approved
0.7188 Intermediate Similarity NPD5222 Approved
0.7172 Intermediate Similarity NPD5211 Phase 2
0.7172 Intermediate Similarity NPD4633 Approved
0.7172 Intermediate Similarity NPD5225 Approved
0.7172 Intermediate Similarity NPD5226 Approved
0.7172 Intermediate Similarity NPD5224 Approved
0.7159 Intermediate Similarity NPD6902 Approved
0.7129 Intermediate Similarity NPD5739 Approved
0.7129 Intermediate Similarity NPD6675 Approved
0.7129 Intermediate Similarity NPD6402 Approved
0.7129 Intermediate Similarity NPD7128 Approved
0.7128 Intermediate Similarity NPD7515 Phase 2
0.7113 Intermediate Similarity NPD5173 Approved
0.7111 Intermediate Similarity NPD4197 Approved
0.71 Intermediate Similarity NPD5175 Approved
0.71 Intermediate Similarity NPD5174 Approved
0.71 Intermediate Similarity NPD4754 Approved
0.7073 Intermediate Similarity NPD4267 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD7524 Approved
0.7065 Intermediate Similarity NPD7750 Discontinued
0.7053 Intermediate Similarity NPD6399 Phase 3
0.7045 Intermediate Similarity NPD7332 Phase 2
0.7041 Intermediate Similarity NPD7638 Approved
0.703 Intermediate Similarity NPD5141 Approved
0.7 Intermediate Similarity NPD4788 Approved
0.699 Remote Similarity NPD6881 Approved
0.699 Remote Similarity NPD7320 Approved
0.699 Remote Similarity NPD6899 Approved
0.6989 Remote Similarity NPD7513 Clinical (unspecified phase)
0.697 Remote Similarity NPD7639 Approved
0.697 Remote Similarity NPD7640 Approved
0.6966 Remote Similarity NPD6898 Phase 1
0.6966 Remote Similarity NPD4692 Approved
0.6966 Remote Similarity NPD4139 Approved
0.6961 Remote Similarity NPD4768 Approved
0.6961 Remote Similarity NPD4767 Approved
0.6957 Remote Similarity NPD4690 Approved
0.6957 Remote Similarity NPD4688 Approved
0.6957 Remote Similarity NPD4689 Approved
0.6957 Remote Similarity NPD6409 Approved
0.6957 Remote Similarity NPD7146 Approved
0.6957 Remote Similarity NPD4693 Phase 3
0.6957 Remote Similarity NPD7521 Approved
0.6957 Remote Similarity NPD5330 Approved
0.6957 Remote Similarity NPD4138 Approved
0.6957 Remote Similarity NPD6684 Approved
0.6957 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6957 Remote Similarity NPD5690 Phase 2
0.6957 Remote Similarity NPD5205 Approved
0.6957 Remote Similarity NPD7334 Approved
0.6947 Remote Similarity NPD5281 Approved
0.6947 Remote Similarity NPD5284 Approved
0.6939 Remote Similarity NPD6084 Phase 2
0.6939 Remote Similarity NPD6083 Phase 2
0.6923 Remote Similarity NPD6372 Approved
0.6923 Remote Similarity NPD3668 Phase 3
0.6923 Remote Similarity NPD6373 Approved
0.6915 Remote Similarity NPD6051 Approved
0.6907 Remote Similarity NPD5210 Approved
0.6907 Remote Similarity NPD4629 Approved
0.6893 Remote Similarity NPD5701 Approved
0.6893 Remote Similarity NPD5697 Approved
0.6875 Remote Similarity NPD5133 Approved
0.6869 Remote Similarity NPD5290 Discontinued
0.6857 Remote Similarity NPD6883 Approved
0.6857 Remote Similarity NPD7290 Approved
0.6857 Remote Similarity NPD7102 Approved
0.6842 Remote Similarity NPD4096 Approved
0.6827 Remote Similarity NPD6011 Approved
0.6827 Remote Similarity NPD5128 Approved
0.6827 Remote Similarity NPD4729 Approved
0.6827 Remote Similarity NPD4730 Approved
0.6809 Remote Similarity NPD6903 Approved
0.6809 Remote Similarity NPD4723 Approved
0.6809 Remote Similarity NPD4722 Approved
0.6804 Remote Similarity NPD7748 Approved
0.6792 Remote Similarity NPD6650 Approved
0.6792 Remote Similarity NPD6617 Approved
0.6792 Remote Similarity NPD6869 Approved
0.6792 Remote Similarity NPD8130 Phase 1
0.6792 Remote Similarity NPD6649 Approved
0.6792 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6792 Remote Similarity NPD6847 Approved
0.6771 Remote Similarity NPD8035 Phase 2
0.6771 Remote Similarity NPD8034 Phase 2
0.6771 Remote Similarity NPD7087 Discontinued
0.6762 Remote Similarity NPD6013 Approved
0.6762 Remote Similarity NPD6014 Approved
0.6762 Remote Similarity NPD6012 Approved
0.6735 Remote Similarity NPD5695 Phase 3
0.6733 Remote Similarity NPD4159 Approved
0.6729 Remote Similarity NPD6882 Approved
0.6729 Remote Similarity NPD8297 Approved
0.6706 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6706 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6698 Remote Similarity NPD5251 Approved
0.6698 Remote Similarity NPD5248 Approved
0.6698 Remote Similarity NPD5249 Phase 3
0.6698 Remote Similarity NPD4634 Approved
0.6698 Remote Similarity NPD5247 Approved
0.6698 Remote Similarity NPD5250 Approved
0.6698 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6698 Remote Similarity NPD5135 Approved
0.6698 Remote Similarity NPD5169 Approved
0.6667 Remote Similarity NPD6928 Phase 2
0.6636 Remote Similarity NPD5216 Approved
0.6636 Remote Similarity NPD5217 Approved
0.6636 Remote Similarity NPD5215 Approved
0.6636 Remote Similarity NPD5127 Approved
0.6632 Remote Similarity NPD4518 Approved
0.6629 Remote Similarity NPD3617 Approved
0.66 Remote Similarity NPD7902 Approved
0.6598 Remote Similarity NPD6050 Approved
0.6596 Remote Similarity NPD6098 Approved
0.6591 Remote Similarity NPD6117 Approved
0.6588 Remote Similarity NPD4245 Approved
0.6588 Remote Similarity NPD4244 Approved
0.6571 Remote Similarity NPD6412 Phase 2
0.6566 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6562 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6552 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6552 Remote Similarity NPD5733 Approved
0.6549 Remote Similarity NPD7503 Approved
0.6535 Remote Similarity NPD5696 Approved
0.6517 Remote Similarity NPD6116 Phase 1
0.6514 Remote Similarity NPD4632 Approved
0.6509 Remote Similarity NPD5168 Approved
0.6505 Remote Similarity NPD7632 Discontinued
0.6495 Remote Similarity NPD5207 Approved
0.6495 Remote Similarity NPD5692 Phase 3
0.6495 Remote Similarity NPD4001 Clinical (unspecified phase)
0.6471 Remote Similarity NPD3698 Phase 2
0.6471 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6471 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6458 Remote Similarity NPD5737 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data